F-star Presents New Data on OX40/CD137 Tetravalent Bispecific Antibody at the SITC 2019 Annual Meeting
F-star Therapeutics (“F-star”), a clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announces that new preclinical data on FS120, a mAb² product candidate targeting OX40 and CD137, will be presented at the Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting in National Harbor, Maryland, United States, being held from 06 - 10 November 2019.
FS120 is a potentially best-in-class dual agonist that has the potential to overcome cancer resistance by simultaneously engaging OX40 (CD134, TNFRSF4) and CD137 (4-1BB), two receptors found on the surface of tumor-infiltrating lymphocytes. Targeting this class of receptors using bispecific tetravalent binding mobilizes multiple arms of the immune system, which research shows is essential for eliminating tumors. F-star’s preclinical data demonstrated that FS120’s crosslink-dependent approach has the potential to provide therapeutic benefit, for example in combination with checkpoint antagonists, and reverse T cell exhaustion in immunosuppressive tumor environments.
Neil Brewis, CSO of F-star said “Recent clinical trials involving agonist molecules have reported that a meaningful anti-cancer response is often associated with liver toxicity, in line with preclinical observations. F-star’s OX40/CD137 mAb² antibody is showing preclinical evidence that an effective tumor-killing response can be decoupled from liver inflammation. We look forward to progressing FS120 into the clinic as we aim to potentially improve treatment outcomes for patients with difficult-to-treat cancers.”
Some CD137 agonist antibodies have been shown to induce adverse effects either in clinical or in preclinical studies as they constitutively activate T cells and thus release cytotoxic immunity outside of the tumor. In contrast, FS120 is designed to mitigate off-target toxicity through conditional, crosslink-dependent activation upon binding to both OX40 and CD137, which are predominantly present on T cells in the tumor microenvironment.
F-star expects to submit an IND application for FS120 during the fourth quarter of 2019.
Details of the poster are below:
Crosslink-independent CD137 agonism is associated with liver inflammation
Abstract poster number: P775
Poster hall location: Prince George AB
Poster hall hours: 07:00 to 20:00 on Friday 08 November 2019
Poster presentation hours: 12:30 to 14:00 and 18:30 to 20:00 on Friday 08 November 2019
- ENDS -
About F-star
F-star is a clinical-stage immuno-oncology company singularly focused on transforming the lives of patients with cancer through the development of its innovative tetravalent mAb2 bispecific antibodies. With four distinct binding sites in a natural human antibody format, F-star believes its proprietary approach will overcome many of the challenges facing current immuno-oncology therapies. F-star’s vision is to transform the treatment of cancer through the development of differentiated and well-tolerated mAb2 bispecific antibodies, which are designed to simultaneously address multiple immune evasion pathways that limit the effect of current immuno-oncology therapies.
mAb2™ is a trademark of F-star.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191108005210/en/
Contact information
For investor enquiries
Lindsey Trickett
VP Investor Relations & Communications
+1 240 543 7970
lindsey.trickett@f-star.com
Consilium Strategic Communications
Chris Gardner, Sue Stuart, David Daley
Tel: +44 (0)20 3709 5700
E-mail: F-star@consilium-comms.com
For media enquiries
Pierre Peotta
Communications Manager
+44 (0)1223 948 094
+44 (0)7392 080 279
pierre.peotta@f-star.com
US
Catherine London, US President
Tel: +1 917-763-2709
E-mail: F-star@consilium-comms.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting Strengthens Digital Transformation Offering with Addition of Internet & Idee21.1.2026 16:30:00 EET | Press release
Andersen Consulting enters into a Collaboration Agreement with Internet & Idee, an Italian-based digital consulting agency, enhancing its ability to deliver integrated, tech-driven solutions. Founded in 1998, Internet & Idee delivers digital strategy, software development, Testing & QA, e-commerce, and mobile solutions. The firm operates across two core areas: IT consulting services and proprietary SaaS products, including credit management and cybersecurity monitoring tools. With deep expertise in banking, insurance, credit management, and luxury e-commerce logistics, Internet & Idee combines sector insight with technical innovation to drive business performance. “This collaboration allows us to apply our digital and sector expertise at greater scale,” said Carlo Stumpo, CEO of Internet & Idee. “Together with Andersen Consulting, we can deliver more targeted, effective solutions for clients facing complex challenges in highly regulated and fast-moving industries.” Mark L. Vorsatz, glo
Technology Innovation Institute and World Economic Forum Announce ‘Abu Dhabi Centre for Frontier Technologies’ at Davos21.1.2026 16:30:00 EET | Press release
The Technology Innovation Institute (TII), the applied research arm of Abu Dhabi’s Advanced Technology Research Council (ATRC), and the World Economic Forum (WEF) have announced the launch of the Abu Dhabi Centre for Frontier Technologies, a new Centre within WEF’s prestigious Centre for the Fourth Industrial Revolution (C4IR) Global Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120284423/en/ Technology Innovation Institute and World Economic Forum Announce ‘Abu Dhabi Centre for Frontier Technologies’ at Davos (Photo: AETOSWire) The collaboration was formalized during a signing ceremony on the sidelines of the World Economic Forum Annual Meeting 2026 in Davos, marking a significant step in deepening international cooperation to shape the future of frontier technologies. Established with a clear mandate to lead breakthroughs in frontier research and development, advance global policy on emerging technologies, and
Volante Technologies introduces Multi-cloud Resiliency Service to ensure non-stop payments processing during major cloud outages21.1.2026 16:00:00 EET | Press release
Volante Technologies, the global leader in Payments as a Service (PaaS), today announced the launch of its premium Multi-cloud Resiliency Service, engineered to keep financial institutions’ payment operations running seamlessly during major cloud provider outages. Built on Volante’s proven cloud-native payments platform, the service provides true cross-cloud continuity, eliminating single-cloud/provider dependency for the payments layer. Recent large-scale outages across hyperscale cloud providers have demonstrated the real-world impact of cloud concentration risk for banks: delayed or failed transactions, SLA penalties, customer churn, operational recovery costs, and reputational damage. While industry research estimates financial sector outages can exceed $2 million per hour, the financial exposure for many large and mid-sized financial institutions far exceeds this average, underscoring why resilience is now a business requirement, not a “nice to have.” “Payments are the lifeblood o
Ras Al Khaimah Ruler Inaugurates 14th Ras Al Khaimah Art Festival21.1.2026 15:50:00 EET | Press release
His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, inaugurated the 14th edition of Ras Al Khaimah Art Festival at Al Jazeera Al Hamra Heritage Village, marking the opening of the Emirate’s flagship annual cultural event. The festival is organized by the Sheikh Saud bin Saqr Al Qasimi Foundation for Policy Research and runs until February 8 under the theme ‘Civilizations’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121583855/en/ Ras Al Khaimah Art Festival, officially opened by His Highness Sheikh Saud bin Saqr Al Qasimi, UAE Supreme Council Member and Ruler of Ras Al Khaimah, has successfully completed its opening weekend, where cultures converged and creativity spoke across borders. (Photo: AETOSWire) Bringing together more than 100 artists from 49 countries, the festival reinforces Ras Al Khaimah’s commitment to culture and the arts as pillars of identity, dialogue a
Duetti Secures $200 Million to Scale Independent Music Catalog Acquisitions and Enhance Platform Capabilities21.1.2026 15:01:00 EET | Press release
Duetti Inc. (“Duetti” or the “Company”), the music-tech and financial services company that empowers independent music creators to unlock the value of their music catalogs, today announces it has secured $200 million in new funding to accelerate music catalog acquisitions and expand its technology and services globally. The financing is led by a $50 million Series C equity investment by Raine Partners, the flagship growth equity fund of The Raine Group, alongside a second $125 million private securitization and a $25 million increase of an existing credit facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121033285/en/ In over three years, Duetti has raised over $635 million, including over $100 million in equity, to support the global independent music community. To date, the Company has partnered with more than 1,100 artists, songwriters, and other music creators across 40+ countries to purchase and manage portion
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom